Climb Bio (CLYM) Operating Leases (2022 - 2026)
Climb Bio (CLYM) posted Operating Leases of $216000.0 for Q1 2026, down 24.21% on a QoQ basis from $285000.0 in Q4 2025, and down 32.29% year-over-year from $319000.0 in Q1 2025.
Climb Bio (CLYM) Operating Leases (2022 - 2026) Analysis & Trends
Climb Bio's Operating Leases history runs 5 years deep, the most recent figure standing at $216000.0 for Q1 2026.
- Quarterly Operating Leases fell 32.29% year-over-year to $216000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $216000.0 (down 32.29% YoY) and the FY2025 annual result came in at $285000.0, down 24.0% from the prior year.
- Operating Leases was $216000.0 for Q1 2026 at Climb Bio, down from $285000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $571000.0 in Q3 2022 and bottomed at $15000.0 in Q4 2023.
- A 5-year average of $267714.3 and a median of $270500.0 in 2022 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases tumbled 91.67% — and 2024, when it jumped 2400.0%.
- Climb Bio's Operating Leases stood at $180000.0 in 2022, then tumbled by 91.67% to $15000.0 in 2023, then soared by 2400.0% to $375000.0 in 2024, then fell by 24.0% to $285000.0 in 2025, then declined by 24.21% to $216000.0 in 2026.
- Business Quant data shows CLYM's Operating Leases at $216000.0 in Q1 2026, $285000.0 in Q4 2025, and $352000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Climb Bio | 870.33 Mn | 870.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 216,000.00 |
| Dec 31, 2025 | 285,000.00 |
| Sep 30, 2025 | 352,000.00 |
| Jun 30, 2025 | 417,000.00 |
| Mar 31, 2025 | 319,000.00 |
| Dec 31, 2024 | 375,000.00 |
| Dec 31, 2023 | 15,000.00 |
| Sep 30, 2023 | 58,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 223,000.00 |
| Dec 31, 2022 | 180,000.00 |
| Sep 30, 2022 | 571,000.00 |
| Jun 30, 2022 | 256,000.00 |
| Mar 31, 2022 | 381,000.00 |